Showing results (21-30 of 53) with videos related to
Sort By:
Pageof 6
Endocrine Journal|July 10, 2020
A case of ezetimibe-effective hypercholesterolemia with a novel heterozygous variant in ABCG5Yujiro Nakano, Chikara Komiya, Hitomi Shimizu, et al.Biochemical and Biophysical Research Communications|June 11, 2016
Expression of inflammation-related genes in aldosterone-producing adenomas with KCNJ5 mutationMasanori Murakami, Takanobu Yoshimoto, Yujiro Nakano, et al.Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|June 16, 2017
Ipragliflozin Reduces Epicardial Fat Accumulation in Non-Obese Type 2 Diabetic Patients with Visceral Obesity: A Pilot StudyTatsuya Fukuda, Ryotaro Bouchi, Masahiro Terashima, et al.BMJ Open Diabetes Research & Care|March 31, 2016
Indirect measure of visceral adiposity 'A Body Shape Index' (ABSI) is associated with arterial stiffness in patients with type 2 diabetesRyotaro Bouchi, Masahiro Asakawa, Norihiko Ohara, et al.The Journal of Nutrition|January 24, 2026
Oxytocin receptor polymorphism rs53576 is linked to habitual alcohol and sucrose intake, as well as liver steatosis, in a general Japanese population cohortHisanori Goto, Yasuhiko Yamamoto, Hiromasa Tsujiguchi, et al.Cardiovascular Diabetology|April 15, 2016
Clinical relevance of dual-energy X-ray absorptiometry (DXA) as a simultaneous evaluation of fatty liver disease and atherosclerosis in patients with type 2 diabetesRyotaro Bouchi, Yujiro Nakano, Norihiko Ohara, et al.Cardiovascular Diabetology|January 22, 2016
Is visceral adiposity a modifier for the impact of blood pressure on arterial stiffness and albuminuria in patients with type 2 diabetes?Ryotaro Bouchi, Norihiko Ohara, Masahiro Asakawa, et al.Journal of Diabetes Investigation|May 17, 2016
Increased visceral adiposity with normal weight is associated with the prevalence of non-alcoholic fatty liver disease in Japanese patients with type 2 diabetesRyotaro Bouchi, Takato Takeuchi, Momoko Akihisa, et al.Cardiovascular Diabetology|March 4, 2017
Luseogliflozin reduces epicardial fat accumulation in patients with type 2 diabetes: a pilot studyRyotaro Bouchi, Masahiro Terashima, Yuriko Sasahara, et al.Journal of Diabetes Investigation|November 21, 2024
Hepatokine leukocyte cell-derived chemotaxin 2 as a biomarker of insulin resistance, liver enzymes, and metabolic dysfunction-associated steatotic liver disease in the general populationKeita Suzuki, Hiromasa Tsujiguchi, Akinori Hara, et al.Pageof 6